ICDcodes.org
FY2027

E13.620Other specified diabetes mellitus with diabetic dermatitis

BillableUnspecified

Is E13.620 billable?

Yes, but E13.620 is an unspecified code. E13.620 is a valid, billable ICD-10-CM code for encounters from October 1, 2026 through September 30, 2027. However, E13.620 is an unspecified or catch-all code. Payers apply additional scrutiny to unspecified codes and many deny them when the medical record supports a more specific option, so check the documentation before selecting E13.620 — the more specific alternatives are listed below.

E13.620 at a glance

CodeE13.620
DescriptionOther specified diabetes mellitus with diabetic dermatitis
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does E13.620 group to?

E13.620 sits in MDC Pre and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 008Simultaneous Pancreas, Islet Cell and Kidney Transplantsurgical

How is E13.620 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to E13.620. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Diabetes, diabeticspecified type NECwithdermatitis (mellitus) (sugar)
  • Diabetes, diabeticspecified type NECwithnecrobiosis lipoidica (mellitus) (sugar)

Inclusion terms

Alternative wording in documentation that is classified to E13.620.

  • Other specified diabetes mellitus with diabetic necrobiosis lipoidica

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E13.620 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E13

The conditions below can never be reported together with E13.620 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • diabetes (mellitus) due to autoimmune process (E10.-)
  • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • type 1 diabetes mellitus (E10.-)

Use additional code — inherited from E13

Report an additional code alongside E13.620 to fully describe the condition. E13.620 is sequenced first.

  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

How long has E13.620 existed?

E13.620 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the E13.62 family? (3)